Study of S-588410 After Adjuvant Chemotherapy for Completely Resected Non-small- Cell Lung Cancer

NCT02410369 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Non-small- Cell Lung Cancer

Interventions

DRUG: S-588410
DRUG: Placebo

Sponsor

Tokyo University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]